Cited by 3,738PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase SignalingMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.

Oncogenic kinase signalling.

Blume-Jensen, Peter, Hunter, Tony·2001·Nature

DOI 10.1038/35077225

Open this paper in CoChat — free account

Abstract

Protein-tyrosine kinases (PTKs) are important regulators of intracellular signal-transduction pathways mediating development and multicellular communication in metazoans. Their activity is normally tightly controlled and regulated. Perturbation of PTK signalling by mutations and other genetic alterations results in deregulated kinase activity and malignant transformation. The lipid kinase phosphoinositide 3-OH kinase (PI(3)K) and some of its downstream targets, such as the protein-serine/threonine kinases Akt and p70 S6 kinase (p70S6K), are crucial effectors in oncogenic PTK signalling. This review emphasizes how oncogenic conversion of protein kinases results from perturbation of the normal autoinhibitory constraints on kinase activity and provides an update on our knowledge about the role of deregulated PI(3)K/Akt and mammalian target of rapamycin/p70S6K signalling in human malignancies.

Integrity signals

Registry

Crossref · 10.1038/35077225

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J., Lydon, N., Kantarjian, H. M., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,237
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,487
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
STATs and Gene Regulation
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno-Jones, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 3,652
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., & Talpaz, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441402 · Cited by 2,713
Signaling—2000 and Beyond
Hunter, T. (2000) · Cell · doi:10.1016/s0092-8674(00)81688-8 · Cited by 2,586
Self-citation

Flagged first, then by citations

Show all 93 references

Research works printed but not linked: 3

Blume-Jensen, P. & Hunter, T. in Encyclopedia of Cancer (ed. Bertino, J. R.) (Academic, San Diego, in the press).
Blume-Jensen, P. & Hunter, T. in Cancer Research - An Encyclopedic Reference (ed. Schwab, M.) (Springer, in the press).
Blume-Jensen, P. & Hunter, T. in Encyclopedia of Cancer (ed. Bertino, J. R.) (Academic, San Diego, in the press).

Sorted by citations

Items 201–300 of 1,008

Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction.
Furdui, C., Lew, E., Schlessinger, J., & Anderson, K. (2006) · Molecules and Cells · doi:10.1016/j.molcel.2006.01.022 · Cited by 259
Regulation and targets of receptor tyrosine kinases
Pawson, T. J. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80597-4 · Cited by 265
PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)
He, M., Cao, C., Ni, Z., Liu, Y., Song, P., Hao, S., He, Y., Sun, X., & Rao, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00999-9 · Cited by 283
Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease
Nakamura, K., Greenwood, A., Binder, L. I., Bigio, E. H., Denial, S., Nicholson, L. K., Zhou, X. Z., & Lu, K. P. (2012) · Cell · doi:10.1016/j.cell.2012.02.016 · Cited by 260
Role of Receptor Tyrosine Kinase Transmembrane Domains in Cell Signaling and Human Pathologies
Li, E., & Hristova, K. A. (2006) · Biochemistry · doi:10.1021/bi060609y · Cited by 266
Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets
Vinayagam, A., Gibson, T. E., Lee, H., Yilmazel, B., Roesel, C. L., Hu, Y., Kwon, Y. V., Sharma, A., Liu, Y., Perrimon, N., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603992113 · Cited by 255
Interactions between growth factor receptors and adhesion molecules: breaking the rules
Comoglio, P. M., Boccaccio, C., & Trusolino, L. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00096-6 · Cited by 255
PIN1 Is an E2F Target Gene Essential for Neu/Ras-Induced Transformation of Mammary Epithelial Cells
Ryo, A., Liou, Y.-C., Wulf, G. M., Nakamura, M., Lee, S. W., & Lu, K. P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5281-5295.2002 · Cited by 254
Dissecting the role of protein phosphorylation: a chemical biology toolbox
Bilbrough, T., Piemontese, E., & Seitz, O. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00991e · Cited by 262
Epidermal Growth Factor Receptor Mediates Increased Cell Proliferation, Migration, and Aggregation in Esophageal Keratinocytes in Vitro and in Vivo
Andl, C. D., Mizushima, T., Nakagawa, H., Oyama, K., Harada, H., Chruma, K., Herlyn, M., & Rustgi, A. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209148200 · Cited by 251
Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23
Li, J., Yang, Y., Yue, P., Austin, R. J., van Eyndhoven, W., Nguyen, K. C. Q., Gabriele, T., McCurrach, M. E., Marks, J. R., Hoey, T. C., et al. (2002) · Nature Genetics · doi:10.1038/ng888 · Cited by 246
Inhibition of protein kinase B/Akt
Hill, M. M. C., & Hemmings, B. A. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00193-6 · Cited by 247
Ba/F3 cells and their use in kinase drug discovery
Warmuth, M., Kim, S., Gu, X.-J., Xia, G., & Adrián, F. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328011a25f · Cited by 240
The regulatory crosstalk between kinases and proteases in cancer
López-Otı́n, C., & Hunter, T. R. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2823 · Cited by 252
Self-citation
Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment
Jiang, B., & Liu, L.-Z. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.03.001 · Cited by 249
Transforming growth factor-β signalling: Role and consequences of Smad linker region phosphorylation
Kamato, D., Burch, M. L., Piva, T. J., Babaahmadi‐Rezaei, H., Rostam, M. A., Xu, S., Zheng, W., Little, P. J., & Osman, N. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.06.001 · Cited by 244
Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs)
Rochette‐Egly, C., & Germain, P. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07005 · Cited by 263
FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions
Antar, A. I., Otrock, Z. K., Jabbour, E., Mohty, M., & Bazarbachi, A. (2020) · Leukemia · doi:10.1038/s41375-019-0694-3 · Cited by 243
Intracellular Signal Transduction Pathway Proteins As Targets for Cancer Therapy
Adjei, A. A., & Hidalgo, M. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.648 · Cited by 250
Pinning down cell signaling, cancer and Alzheimer's disease
Lu, K. P. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.02.002 · Cited by 239
Phosphorylation-specific prolyl isomerization: is there an underlying theme?
Wulf, G. M., Finn, G., Suizu, F., & Lu, K. P. (2005) · Nature Cell Biology · doi:10.1038/ncb0505-435 · Cited by 240
Activation of Akt Predicts Poor Outcome in Neuroblastoma
Opel, D., Poremba, C., Simon, T., Debatin, K., & Fulda, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2201 · Cited by 238
Inactivation of NF-κB by genistein is mediated via Akt signaling pathway in breast cancer cells
Gong, L., Li, Y., Nedeljkovic-Kurepa, A., & Sarkar, F. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206583 · Cited by 240
Tyrosine kinase inhibitors in cancer therapy
Madhusudan, S., & Ganesan, T. S. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.05.006 · Cited by 236
Escape from Cbl-mediated downregulation
Peschard, P., & Park, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00136-3 · Cited by 235
Protein microarrays: Molecular profiling technologies for clinical specimens
Espina, V. A., Mehta, A. I., Winters, M. E., Calvert, V. S., Wulfkuhle, J. D., Petricoin, E. F., & Liotta, L. A. (2003) · PROTEOMICS · doi:10.1002/pmic.200300592 · Cited by 235
Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
Beretta, G. L., Cassinelli, G., Pennati, M., Zuco, V., & Gatti, L. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.062 · Cited by 239
Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy
Koikawa, K., Kibe, S., Suizu, F., Sekino, N., Kim, N., Manz, T. D., Pinch, B. J., Akshinthala, D., Verma, A., Gaglia, G., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.020 · Cited by 243
An Activated ErbB3/NRG1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer Cells
Sheng, Q., Liu, X., FLEMING, E. M., Yuan, K., Piao, H., Chen, J., MOUSTAFA, Z. R., Thomas, R. K., Greulich, H. E., Schinzel, A. C., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.047 · Cited by 234
Structural Evidence for Loose Linkage between Ligand Binding and Kinase Activation in the Epidermal Growth Factor Receptor
Lu, C., Mi, L.-Z., Grey, M. J., Zhu, J., Graef, E. R., Yokoyama, S., & Springer, T. A. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00742-10 · Cited by 234
Clinical development of targeted and immune based anti-cancer therapies
Seebacher, N. A., Stacy, A. E., Porter, G., & Merlot, A. M. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1094-2 · Cited by 241
Cell metabolism in the regulation of programmed cell death
Plas, D. R., & Thompson, C. B. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00528-8 · Cited by 232
Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy
Webb, T. R., Slavish, J., George, R. E., Look, A. T., Xue, L., Jiang, Q., Cui, X., Rentrop, W. B., & Morris, S. W. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.9.3.331 · Cited by 240
Mammalian Target of Rapamycin (mTOR): Pro- and Anti-Apoptotic
Castedo, M., Ferri, K. F., & Kroemer, G. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400978 · Cited by 230
Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment
Kopfstein, L., & Christofori, G. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5296-8 · Cited by 236
In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR).
Nickerson, T., Chang, F., Lorimer, D., Smeekens, S. P., Sawyers, C. L., & Pollak, M. (2001) · PubMed · Cited by 230
Neural and Head Induction by Insulin-like Growth Factor Signals
Pera, E. M., Wessely, O., Li, S.-Y., & Robertis, E. M. D. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00069-7 · Cited by 229
Anaplastic lymphoma kinase proteins in growth control and cancer
Pulford, K. A. F., Morris, S. W., & Turturro, F. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.10472 · Cited by 226
Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer
Berx, G., Raspé, E., Christofori, G., Thiery, J. P., & Sleeman, J. P. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9114-6 · Cited by 232
Structures of the Cancer-Related Aurora-A, FAK, and EphA2 Protein Kinases from Nanovolume Crystallography
Nowakowski, J., Cronin, C. N., McRee, D. E., Knuth, M. W., Nelson, C. G., Pavletich, N. P., Rogers, J., Sang, B., Scheibe, D. N., Swanson, R. V., et al. (2002) · Structure · doi:10.1016/s0969-2126(02)00907-3 · Cited by 227
Crizotinib for the Treatment of ALK-Rearranged Non-Small Cell Lung Cancer: A Success Story to Usher in the Second Decade of Molecular Targeted Therapy in Oncology
Ou, S. I., Bartlett, C. H., Mino-Kenudson, M. A., Cui, J., & Iafrate, A. J. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0311 · Cited by 226
Control of mammalian oocyte growth and early follicular development by the oocyte PI3 kinase pathway: New roles for an old timer
Liu, K., Singareddy, R., Liu, L., Jagarlamudi, K., Boman, K., Selstam, G., & Reddy, P. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.07.038 · Cited by 227
The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12449 · Cited by 222
GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion
Morishige, M., Hashimoto, S., Ogawa, E., Toda, Y., Kotani, H., Hirose, M., Wei, S., Hashimoto, A., Yamada, A., Yano, H., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1672 · Cited by 225
FMS-like Tyrosine Kinase 3/FLT3: From Basic Science to Clinical Implications
Kazi, J. U., & Rönnstrand, L. (2019) · Physiological Reviews · doi:10.1152/physrev.00029.2018 · Cited by 223
KEA: kinase enrichment analysis
Lachmann, A., & Ma’ayan, A. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp026 · Cited by 214
The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.
Ayala, G., Wang, D.-G., Wulf, G. M., Frolov, A., Li, R., Sowadski, J. M., Wheeler, T. M., Lu, K. P., & Bao, L. (2003) · PubMed · Cited by 217
Mechanisms of Activation of Receptor Tyrosine Kinases: Monomers or Dimers
MARUYAMA, I. N. (2014) · Cells · doi:10.3390/cells3020304 · Cited by 228
Classifying the medulloblastoma: insights from morphology and molecular genetics
Ellison, D. W. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00419.x · Cited by 217
Versatile Fluorescence Probes of Protein Kinase Activity
Shults, M. D., & Imperiali, B. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0380502 · Cited by 217
The c‐myc Promoter: Still MysterY and Challenge
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99004-1 · Cited by 211
Increased Incidence of Well-Differentiated Thyroid Cancer Associated with Hashimoto Thyroiditis and the Role of the PI3k/Akt Pathway
Larson, S. D., Jackson, L. N., Riall, T. S., Uchida, T., Thomas, R. P., Qiu, S., & Evers, B. M. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2006.12.037 · Cited by 216
PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomasPreprint
Ozawa, T., Brennan, C., Wang, L., Squatrito, M., Sasayama, T., Nakada, M., Huse, J. T., Pedraza, A. M., Utsuki, S., Yasui, Y., et al. (2010) · Genes & Development · doi:10.1101/gad.1972310 · Cited by 225
Flt3-dependent transformation by inactivating c-Cbl mutations in AML
Sargin, B., Choudhary, C., Crosetto, N., Schmidt, M. H. H., Grundler, R., Rensinghoff, M., Thiessen, C., Tickenbrock, L., Schwäble, J., Brandts, C., et al. (2007) · Blood · doi:10.1182/blood-2007-01-066076 · Cited by 220
AXL Is a Potential Target for Therapeutic Intervention in Breast Cancer Progression
Zhang, Y., Knyazev, P. G., Cheburkin, Y. V., Sharma, K., Knyazev, Y. P., Őrfi, L., Szabadkai, I., Daub, H., Kéri, G., & Ullrich, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2661 · Cited by 217
Prognostic value ofERBBfamily mRNA expression in breast carcinomas
Bièche, I., Onody, P., Tozlu, S., Driouch, K., Vidaud, M., & Lidereau, R. (2003) · International Journal of Cancer · doi:10.1002/ijc.11273 · Cited by 214
Detection of FLT3 Internal Tandem Duplication and D835 Mutations by a Multiplex Polymerase Chain Reaction and Capillary Electrophoresis Assay
Murphy, K. M., Levis, M. J., Hafez, M. J., Geiger, T., Cooper, L., Smith, B. D., Small, D., & Berg, K. D. (2003) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60458-8 · Cited by 214
VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy
Rahimi, N. (2006) · Frontiers in bioscience · doi:10.2741/1839 · Cited by 222
Clinical Proteomics
Liotta, L. A., Kohn, E. C., & Petricoin, E. F. (2001) · JAMA · doi:10.1001/jama.286.18.2211 · Cited by 213
Defective downregulation of receptor tyrosine kinases in cancer
Bache, K. G., Slagsvold, T., & Stenmark, H. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600292 · Cited by 213
Targeted therapies in pulmonary arterial hypertension
Montani, D., Chaumais, M., Guignabert, C., Günther, S., Girerd, B., Jaïs, X., Algalarrondo, V., Price, L., Savale, L., Sitbon, O., et al. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.002 · Cited by 224
Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21)
Charest, A., Lane, K. M., McMahon, K., Park, J., Preisinger, E., Conroy, H., & Housman, D. E. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10207 · Cited by 212
Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T
Zhang, X., Guo, A., Yu, J., Possemato, A. P., Chen, Y., Zheng, W., Polakiewicz, R. D., Kinzler, K. W., Vogelstein, B., Velculescu, V. E., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611665104 · Cited by 214
Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor
Albert, D. H., Tapang, P., Magoc, T. J., Pease, L. J., Reuter, D. R., Wei, R.-Q., Li, J., Guo, J., Bousquet, P. F., Ghoreishi-Haack, N. S., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0410 · Cited by 209
Flavonoids as Protein Kinase Inhibitors for Cancer Chemoprevention: Direct Binding and Molecular Modeling
Hou, D., & Kumamoto, T. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2816 · Cited by 216
Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells.
de Sande, T. V., Schrijver, E. D., Heyns, W., Verhoeven, G., & Swinnen, J. V. (2002) · PubMed · Cited by 209
Molecular mechanisms underlying IGF‐I‐induced attenuation of the growth‐inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells
Lu, Y., Zi, X., & Pollak, M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11445 · Cited by 212
Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma
Gunawardana, J., Chan, F. C., Telenius, A., Woolcock, B. W., Kridel, R., Tan, K. L., Ben‐Neriah, S., Mottok, A., Lim, R. S., Boyle, M., et al. (2014) · Nature Genetics · doi:10.1038/ng.2900 · Cited by 216
Tuberous sclerosis complex tumor suppressor–mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent
Jaeschke, A., Hartkamp, J., Saitoh, M., Roworth, W., Nobukuni, T., Hodges, A., Sampson, J. R., Thomas, G., & Lamb, R. F. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.jcb.200206108 · Cited by 208
Grb2 signaling in cell motility and cancer
Giubellino, A., Burke, T. R., & Bottaro, D. P. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.8.1021 · Cited by 215
Fusion Tyrosine Kinases Induce Drug Resistance by Stimulation of Homology-Dependent Recombination Repair, Prolongation of G 2 /M Phase, and Protection from Apoptosis
Słupianek, A., Hoser, G., Majsterek, I., Bronisz, A., Malecki, M. T., Błasiak, J., Fishel, R. A., & Skórski, T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4189-4201.2002 · Cited by 205
Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis
Wulf, G. M., Garg, P., Liou, Y., Iglehart, D., & Lu, K. P. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600323 · Cited by 201
The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer
Acquaviva, J., Wong, R., & Charest, A. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.07.006 · Cited by 205
Activated Cdc42 Sequesters c-Cbl and Prevents EGF Receptor Degradation
Wu, W. J., Tu, S. S., & Cerione, R. A. (2003) · Cell · doi:10.1016/s0092-8674(03)00688-3 · Cited by 203
Prolyl isomerase Pin1 in cancer
Lu, Z., & Hunter, T. R. (2014) · Cell Research · doi:10.1038/cr.2014.109 · Cited by 205
Self-citation
Met/Hepatocyte Growth Factor Receptor Ubiquitination Suppresses Transformation and Is Required for Hrs Phosphorylation
Abella, J. V., Peschard, P., Naujokas, M. A., Lin, T., Saucier, C., Urbé, S., & Park, M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9632-9645.2005 · Cited by 203
Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2
Liu, H., Radisky, D. C., Nelson, C. M., Zhang, H., Fata, J. E., Roth, R. A., & Bissell, M. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511342103 · Cited by 203
Activation of Tyrosine Kinases in Cancer
Vlahovic, G., & Crawford, J. (2003) · The Oncologist · doi:10.1634/theoncologist.8-6-531 · Cited by 202
Frequent Alterations in the Expression of Serine/Threonine Kinases in Human Cancers
Capra, M. C., Nuciforo, P. G., Confalonieri, S., Quarto, M., Bianchi, M., Nebuloni, M., Boldorini, R. L., Pallotti, F., Viale, G., Gishizky, M. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3489 · Cited by 196
Tumor-targeting peptides from combinatorial libraries
Liu, R., Li, X., Xiao, W., & Lam, K. S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.009 · Cited by 200
The secret life of kinases: functions beyond catalysis
Rauch, J., Volinsky, N., Romano, D., & Kölch, W. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-23 · Cited by 209
Tyrosine kinase receptors as attractive targets of cancer therapy
Bennasroune, A., Gardin, A., Aunis, D., Crémel, G., & Hubert, P. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.08.004 · Cited by 199
Redox Regulation of Epidermal Growth Factor Receptor Signaling through Cysteine Oxidation
Truong, T. H., & Carroll, K. S. (2012) · Biochemistry · doi:10.1021/bi301441e · Cited by 199
Regulation of a Transient Receptor Potential (TRP) Channel by Tyrosine Phosphorylation
Xu, H., Zhao, H., Tian, W., Yoshida, K., Roullet, J., & Cohen, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211061200 · Cited by 196
Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy
Zarling, A. L., Polefrone, J. M., Evans, A. M., Mikesh, L. M., Shabanowitz, J., Lewis, S. T., Engelhard, V. H., & Hunt, D. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604045103 · Cited by 196
Isoelectric focusing technology quantifies protein signaling in 25 cells
O’Neill, R. A., Bhamidipati, A., Bi, X., Deb-Basu, D., Cahill, L., Ferrante, J. A., Gentalen, E., Glazer, M., Gossett, J. J., Hacker, K. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607973103 · Cited by 194
Regulation of endocytosis via the oxygen-sensing pathway
Wang, Y., Roche, O., Yan, M. S., Finak, G., Evans, A. J., Metcalf, J. L., Hast, B. E., Hanna, S. C., Wondergem, B., Furge, K. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1922 · Cited by 198
Chemical and biotechnological developments in organotin cancer chemotherapy
Tabassum, S., & Pettinari, C. (2006) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2005.12.033 · Cited by 193
Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line
Yoon, J., Higuchi, H., Werneburg, N. W., Kaufmann, S. H., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32410 · Cited by 193
Human CD4+ T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune function
Haines, C. J., Giffon, T. D., Lu, L.-S., Lu, X., Tessier-Lavigne, M., Ross, D. T., & Lewis, D. B. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20080996 · Cited by 189
Review: Recent Developments in Enzyme-Based Biosensors for Biomedical Analysis
Ispas, C. R., Crivat, G., & Andreescu, S. (2012) · Analytical Letters · doi:10.1080/00032719.2011.633188 · Cited by 202
Analysis of the Human TrkB Gene Genomic Organization Reveals Novel TrkB Isoforms, Unusual Gene Length, and Splicing Mechanism
Stoilov, P., Ċastrén, E., & Stamm, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6301 · Cited by 191
Design, synthesis and anticancer evaluation of thieno[2,3-d]pyrimidine derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers
El‐Metwally, S. A., Saied, K. F., Eissa, I. H., & Elkaeed, E. B. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102944 · Cited by 191
The path to the clinic: a comprehensive review on direct KRASG12C inhibitors
Kwan, A. K., Piazza, G. A., Keeton, A. B., & Leite, C. A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02225-w · Cited by 200
Application of Petri net based analysis techniques to signal transduction pathways
Sackmann, A., Monika Heiner, A., & Koch, I. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-482 · Cited by 189
Functional and therapeutic significance of Akt deregulation in malignant melanoma
Robertson, G. P. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-1577-9 · Cited by 187
Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas.
Narita, Y., Nagane, M., Mishima, K., Huang, H.-J. S., Furnari, F. B., & Cavenee, W. K. (2002) · PubMed · Cited by 189
An efficient rapid system for profiling the cellular activities of molecular libraries
Melnick, J. S., Janes, J. O., Kim, S., Chang, J., Sipes, D. G., Gunderson, D., Jarnes, L., Matzen, J., Garcia, M. E., Hood, T. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511292103 · Cited by 188
Signalling pathways regulating the invasive differentiation of human trophoblasts: a review
Pollheimer, J., & Knöfler, M. (2005) · Placenta · doi:10.1016/j.placenta.2004.11.013 · Cited by 186
Protein microarray detection strategies: focus on direct detection technologies
Espina, V. A., Woodhouse, E. C., Wulfkuhle, J. D., Asmussen, H. D., Petricoin, E. F., & Liotta, L. A. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.04.013 · Cited by 184

Authors: Blume-Jensen, P., & Hunter, T.
Affiliations: Salk Institute for Biological Studies (US)
ORCID: Hunter, Tony
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2001-05-01
Volume: 411
Issue: 6835
Pages: 355-365
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/35077225
OpenAlex: W1639582946
Cited by: 3,738
References: 93
Citations by year: 2026: 48 · 2025: 69 · 2024: 87 · 2023: 102 · 2022: 103 · 2021: 114 · 2020: 121 · 2019: 118 · 2018: 105 · 2017: 119 · 2016: 131 · 2015: 156 · 2014: 186 · 2013: 185 · 2012: 200
FWCI: 12.95
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: tyrosine kinase, oncogenic signaling, signal transduction, phosphatidylinositol 3-kinase, Akt, p70 S6 kinase, mTOR, kinase autoinhibition, malignant transformation, human malignancies
MeSH terms: Animals, Humans, Mutation, Neoplasms, Oncogenes, Protein-Tyrosine Kinases, Signal Transduction, Oncogene Proteins, Retroviridae Proteins, Oncogenic, Phosphatidylinositol 3-Kinases, Ribosomal Protein S6 Kinases, Receptor Protein-Tyrosine Kinases, Oncogene Protein v-akt

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oncogenic kinase signalling.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks